Recruiting Clinical Trials

Displaying 81 - 90 of 242 result(s)
Study Title Condition Phase Location
A Phase I, Open-label, Multicenter, Study of WVT078 in Subjects With Relapsed and/or Refractory Multiple Myeloma Multiple Myeloma (MM) Phase 1
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Germany
  • Country: 
A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Systemic Pharmacokinetics of Icenticaftor in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Control Participants Hepatic Failure Phase 1
  • Country: 
    United States
A Phase I/Ib, Open-label, Multi-center, Study of KAZ954 as a Single Agent and in Combination With Spartalizumab, NZV930 and NIR178 in Patients With Advanced Solid Tumors Solid Tumors Phase 1
  • Country: 
    United States
  • Country: 
    Canada
  • Country: 
    Hong Kong
  • Country: 
An Open Label Cryptosporidium Controlled Human Infection Model (CHIM) to Assess the Efficacy and Safety of ABO809 in Healthy Participants Cryptosporidium Infection, Cryptosporidiosis Phase 1
  • Country: 
    United States
A Phase II, Open-label, Single Arm Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Twice Daily Midostaurin (PKC412) Combined With Standard Chemotherapy and as a Single Agent Post-consolidation Therapy in Children With Untreated FLT3-m ... FLT3-mutated Acute Myeloid Leukemia Phase 2
  • Country: 
    United States
  • Country: 
    Austria
  • Country: 
    Czech Republic
  • Country: 
A Post Marketing Surveillance on Lutathera® (Lutetium (177Lu) Oxodotreotide, 177Lu-DOTA0-Tyr3-Octreotate) in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) in Korea Somatostatin Receptor-positive GEP-NET Not Given
  • Country: 
    Korea, Republic of
A Randomized, Participant and Investigator Masked, Placebo-controlled, Multicenter, Proof-of-concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) in Patients With Early and Intermediate Age-related Macular Degeneration Age-Related Macular Degeneration Phase 2
  • Country: 
    United States
A Randomized, Placebo-controlled, Investigator- and Participant-blinded Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation Atrial Fibrillation Phase 2
  • Country: 
    United States
  • Country: 
    Germany
Open Label, Multi-center, Phase IV Study of Ruxolitinib or Ruxolitinib and Panobinostat Combination, for Patients Who Have Completed Prior Global Novartis or Incyte Sponsored Studies Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia, Thalassemia Phase 4
  • Country: 
    Belgium
  • Country: 
    Chile
  • Country: 
    China
  • Country: 
A Randomized, Multicenter, Open-label Trial Comparing the Effectiveness of an "Inclisiran First" Implementation Strategy to Usual Care on LDL Cholesterol (LDL-C) in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C (≥70 mg/dL) D ... Atherosclerotic Cardiovascular Disease Phase 3
  • Country: 
    United States